UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 333

Sortiert nach

Duration of Antibiotic Therapy: Shorter Is Better

Annals of internal medicine, 2019-08, Vol.171 (3), p.210

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges

Clinical microbiology reviews, 2017-01, Vol.30 (1), p.409-447

2017

Link zum Volltext

Verfügbarkeit prüfen

Sustainable Discovery and Development of Antibiotics — Is a Nonprofit Approach the Future?

The New England journal of medicine, 2019-08, Vol.381 (6), p.503-505

2019

Link zum Volltext

Verfügbarkeit prüfen

SERPINB1-mediated checkpoint of inflammatory caspase activation

Nature immunology, 2019-03, Vol.20 (3), p.276

2019

Link zum Volltext

Verfügbarkeit prüfen

A method for generation phage cocktail with great therapeutic potential

PloS one, 2012-03, Vol.7 (3), p.e31698-e31698

2012

Link zum Volltext

Verfügbarkeit prüfen

Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes

Clinical infectious diseases, 2020-02, Vol.70 (4), p.566-573

2020

Link zum Volltext

Verfügbarkeit prüfen

The future of antibiotics

Critical care (London, England), 2014-06, Vol.18 (3), p.228-228

Spellberg, Brad

2014

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy

PloS one, 2011-09, Vol.6 (9), p.e24198-e24198

2011

Link zum Volltext

Verfügbarkeit prüfen

Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management

Clinical Microbiology Reviews, 2005-07, Vol.18 (3), p.556-569

2005

Link zum Volltext

Verfügbarkeit prüfen

Current Treatment Strategies for Disseminated Candidiasis

Clinical infectious diseases, 2006-01, Vol.42 (2), p.244-251

2006

Link zum Volltext

Verfügbarkeit prüfen

Combination Polyene-Caspofungin Treatment of Rhino-Orbital-Cerebral Mucormycosis

Clinical infectious diseases, 2008-08, Vol.47 (3), p.364-371

2008

Link zum Volltext

Verfügbarkeit prüfen

S1497 Optimizing Percutaneous Endoscopic Gastrostomy Tube Placement Wait Times in a Safety Net Hospital

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e1073-e1074

2022

Link zum Volltext

Verfügbarkeit prüfen

The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial

Journal of antimicrobial chemotherapy, 2012-03, Vol.67 (3), p.715-722

2012

Link zum Volltext

Verfügbarkeit prüfen

Capsule carbohydrate structure determines virulence in Acinetobacter baumannii

PLoS pathogens, 2021-02, Vol.17 (2), p.e1009291-e1009291

2021

Link zum Volltext

Verfügbarkeit prüfen

Seasonal and temperature-associated increases in gram-negative bacterial bloodstream infections among hospitalized patients

PloS one, 2011-09, Vol.6 (9), p.e25298-e25298

2011

Link zum Volltext

Verfügbarkeit prüfen

The iron chelator deferasirox protects mice from mucormycosis through iron starvation

The Journal of clinical investigation, 2007-09, Vol.117 (9), p.2649-2657

2007

Link zum Volltext

Verfügbarkeit prüfen

Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates

PloS one, 2023-06, Vol.18 (6), p.e0287102-e0287102

2023

Link zum Volltext

Verfügbarkeit prüfen

Molecular Epidemiology of Carbapenem-Nonsusceptible Acinetobacter baumannii in the United States

Journal of Clinical Microbiology, 2011-11, Vol.49 (11), p.3849-3854

2011

Link zum Volltext

Verfügbarkeit prüfen

Novel insights into disseminated candidiasis: pathogenesis research and clinical experience converge

PLoS pathogens, 2008-02, Vol.4 (2), p.e38-e38

Spellberg, Brad

2008

Link zum Volltext

Verfügbarkeit prüfen

Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment

PloS one, 2012-08, Vol.7 (8), p.e41290-e41290

2012

Link zum Volltext

Verfügbarkeit prüfen

Recent Advances in the Management of Mucormycosis: From Bench to Bedside

Clinical infectious diseases, 2009-06, Vol.48 (12), p.1743-1751

2009

Link zum Volltext

Verfügbarkeit prüfen

Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome

PloS one, 2012-05, Vol.7 (5), p.e37375-e37375

2012

Link zum Volltext

Verfügbarkeit prüfen

Horizontal Gene Transfer of Antibiotic Resistance from Acinetobacter baylyi to Escherichia coli on Lettuce and Subsequent Antibiotic Resistance Transmission to the Gut Microbiome

mSphere, 2020-05, Vol.5 (3)

2020

Link zum Volltext

Verfügbarkeit prüfen

Trends in Antimicrobial Drug Development: Implications for the Future

Clinical infectious diseases, 2004-05, Vol.38 (9), p.1279-1286

2004

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal Antibody Requires Immunomodulation for Efficacy Against Acinetobacter baumannii Infection

The Journal of infectious diseases, 2021-12, Vol.224 (12), p.2133-2147

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 333

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(316)
Mit Volltextzugriff
(305)

Publikationsform

Sprache

Englisch
(333)
Japanisch
(38)

Erscheinungsjahr

n.n

Thema

Science & Technology
(252)
Life Sciences & Biomedicine
(218)
Humans
(176)
Infectious Diseases
(152)
Microbiology
(143)
Immunology
(98)
Animals
(81)
Mice
(69)
Biological And Medical Sciences
(68)
Antibiotics
(66)
Infections
(66)
Male
(66)
Medical Sciences
(58)
Female
(50)
Anti-Bacterial Agents - Therapeutic Use
(47)
General & Internal Medicine
(40)
Mice, Inbred Balb C
(37)
Medicine
(35)
Drug Resistance
(33)
Medicine, General & Internal
(33)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Duration of Antibiotic Therapy: Shorter Is Better

Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges

Sustainable Discovery and Development of Antibiotics — Is a Nonprofit Approach the Future?

SERPINB1-mediated checkpoint of inflammatory caspase activation

A method for generation phage cocktail with great therapeutic potential

Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes

The future of antibiotics

Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy

Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management

Current Treatment Strategies for Disseminated Candidiasis

Combination Polyene-Caspofungin Treatment of Rhino-Orbital-Cerebral Mucormycosis

S1497 Optimizing Percutaneous Endoscopic Gastrostomy Tube Placement Wait Times in a Safety Net Hospital

The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial

Capsule carbohydrate structure determines virulence in Acinetobacter baumannii

Seasonal and temperature-associated increases in gram-negative bacterial bloodstream infections among hospitalized patients

The iron chelator deferasirox protects mice from mucormycosis through iron starvation

Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates

Molecular Epidemiology of Carbapenem-Nonsusceptible Acinetobacter baumannii in the United States

Novel insights into disseminated candidiasis: pathogenesis research and clinical experience converge

Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment

Recent Advances in the Management of Mucormycosis: From Bench to Bedside

Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome

Horizontal Gene Transfer of Antibiotic Resistance from Acinetobacter baylyi to Escherichia coli on Lettuce and Subsequent Antibiotic Resistance Transmission to the Gut Microbiome

Trends in Antimicrobial Drug Development: Implications for the Future

Monoclonal Antibody Requires Immunomodulation for Efficacy Against Acinetobacter baumannii Infection

Suchergebnisse filtern